Report Cover

Global Meningococcal Vaccine Market by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers) and Regional Forecasting 2020-2027


Global Meningococcal Vaccine Market Size to reach USD 4.38 Billion by 2027.

Global Meningococcal Vaccine Market was valued at USD 2.11 Billion in 2019 and expected to grow with a CAGR 9.5% over the forecast period 2020-2027. Meningococcal Vaccine is used in Invasive meningococcal disease. Invasive meningococcal disease (IMD) is a bacterial virus with a variety of diseases involving meningitis, bacteremia (meningococcemia), and bacteremia pneumonia affected by a gram-negative coccus, Neisseria meningitidis. The meningococcal disease is rare, if left unchecked, it is associated with a high mortality risk of up to 50% and commonly leads to severe complications afterwards. The disease is usually spread by patients or asymptomatic carriers via close contact with droplets of respiratory or throat secretions. N. (Neisseria)Various serotypes of N. Meningitidis are found in 12 serogroups, of which only 5 serogroups are responsible for most of diseases worldwide, including A, B, C, W, and Y. Surge in immunization programs across the globe and increase in outbreaks of meningococcal disease drive the market globally. For instance, as per the World Health Organisation, Meningococcal meningitis is observed worldwide but highly sub-Saharan Africa and stretching from Senegal in the west to Ethiopia in the east affected from this diseased, around 30000 cases are still recorded each year in these areas. Furthermore, increase in research and development for vaccine technology also propel market growth. Despite that, longer timelines required for vaccine production and high costs associated with the development of vaccines restraint the market growth over the forecasting period 2020-2027. The regional analysis of the Meningococcal Vaccine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America and Europe dominate the market owing to surge in outbreaks for meningococcal diseases and awareness for meningococcal diseases, ease of product availability in these regions. However, APAC is registered the fastest growth due to steady meningococcal vaccine market growth in the region. Key Players in Global Meningococcal Vaccine Market Bio-Manguinhos Bio-Med Pvt. Limited Chongqing Zhifei Biological Products Co., Ltd. GlaxoSmithKline Plc Hualan Biological Engineering Inc. Incepta Pharmaceuticals Ltd. Pfizer Inc. Sanofi S.A Serum institute of India Pvt. Ltd Walvax Biotechnology Co., Ltd The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Vaccine Serotype: MenACWY MenB & Manic MenC MenA MenAC By Vaccine Type: Conjugate Polysaccharide Subcapsular By End Users: Paediatric Adult Travelers By Region: North America U.S. Canada Europe UK Germany France Spain Italy Asia Pacific China India Japan Australia Latin America Brazil Mexico Rest of LA Rest of the World Furthermore, years considered for the study are as follows: Historical year - 2017, 2018 Base year - 2019 Forecast period - 2020 to 2027 Target Audience of Global Meningococcal Vaccine Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Meningococcal Vaccine Market, by Vaccine Serotype, 2018-2027 (USD Billion)
1.2.2.	Meningococcal Vaccine Market, by Vaccine Type, 2018-2027 (USD Billion)
1.2.3.	Meningococcal Vaccine Market, by End Users, 2018-2027 (USD Billion
1.2.4.	Meningococcal Vaccine Market, By Region, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Meningococcal Vaccine Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Meningococcal Vaccine Market Dynamics	
3.1.	Meningococcal Vaccine Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Meningococcal Vaccine Market Industry Analysis
4.1.	Porter's 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economic
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
4.1.	Global Meningococcal Vaccine Market, by Vaccine Serotype
4.2.	Market Snapshot 
4.3.	Global Meningococcal Vaccine Market by Source, Performance - Potential Analysis
4.4.	Global Meningococcal Vaccine Market Estimates & Forecasts by Vaccine Serotype 2018-2027 (USD Billion)
4.5.	Meningococcal Vaccine Market, Sub Segment Analysis
4.5.1.	MenACWY
4.5.2.	MenB & Manic
4.5.3.	MenC
4.5.4.	MenA
4.5.5.	MenAC
Chapter 5.	Global Meningococcal Vaccine Market, by Vaccine Type
5.1.	Market Snapshot 
5.2.	Global Meningococcal Vaccine Market by Source, Performance - Potential Analysis
5.3.	Global Meningococcal Vaccine Market Estimates & Forecasts by Vaccine Type 2018-2027 (USD Billion)
5.4.	Meningococcal Vaccine Market, Sub Segment Analysis
5.4.1.	 Conjugate
5.4.2.	Polysaccharide
5.4.3.	Subcapsular
Chapter 6.	Global Meningococcal Vaccine Market, by End Users
6.1.	Market Snapshot 
6.2.	Global Meningococcal Vaccine Market by Source, Performance - Potential Analysis
6.3.	Global Meningococcal Vaccine Market Estimates & Forecasts by End Users 2018-2027 (USD Billion)
6.4.	Meningococcal Vaccine Market, Sub Segment Analysis
6.4.1.	Paediatric
6.4.2.	Adult
6.4.3.	Travelers
Chapter 7.	Global Meningococcal Vaccine Market, Regional Analysis
7.1.	Meningococcal Vaccine Market, Regional Market Snapshot 
7.2.	North America Meningococcal Vaccine Market 
7.2.1.	U.S. Meningococcal Vaccine Market
7.2.1.1.	Vaccine Serotype breakdown estimates & forecasts, 2018-2027
7.2.1.2.	Vaccine Type breakdown estimates & forecasts, 2018-2027
7.2.1.3.	End Users breakdown estimates & forecasts, 2018-2027
7.2.2.	Canada Meningococcal Vaccine Market
7.3.	Europe Meningococcal Vaccine Market Snapshot
7.3.1.	U.K. Meningococcal Vaccine Market 
7.3.2.	Germany Meningococcal Vaccine Market
7.3.3.	France Meningococcal Vaccine Market
7.3.4.	Spain Meningococcal Vaccine Market
7.3.5.	Italy Meningococcal Vaccine Market
7.3.6.	Rest of Europe Meningococcal Vaccine Market
7.4.	Asia-Pacific Meningococcal Vaccine Market Snapshot
7.4.1.	China Meningococcal Vaccine Market 
7.4.2.	India Meningococcal Vaccine Market 
7.4.3.	Japan Meningococcal Vaccine Market
7.4.4.	Australia Meningococcal Vaccine Market
7.5.	Latin America Meningococcal Vaccine Market Snapshot 
7.6.	Rest of The World Meningococcal Vaccine Market
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profile
8.2.1.	 Bio-Manguinhos
8.2.1.1.	   Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	Bio-Med Pvt. Limited
8.2.3.	Chongqing Zhifei Biological Products Co., Ltd.
8.2.4.	GlaxoSmithKline Plc
8.2.5.	Hualan Biological Engineering Inc.
8.2.6.	Incepta Pharmaceuticals Ltd.
8.2.7.	Pfizer Inc.
8.2.8.	Sanofi S.A
8.2.9.	Serum institute of India Pvt. Ltd
8.2.10.	Walvax Biotechnology Co., Ltd.
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

List of Tables TABLE 1. Global Meningococcal Vaccine Market, report scope TABLE 2. Global Meningococcal Vaccine Market estimates & forecasts by region 2018-2027 (USD Billion) TABLE 3. Global Meningococcal Vaccine Market estimates & forecasts by Vaccine Serotype, 2018-2027 (USD Billion) TABLE 4. Global Meningococcal Vaccine Market estimates & forecasts by Vaccine Type, 2018-2027 (USD Billion) TABLE 5. Global Meningococcal Vaccine Market estimates & forecasts by End Users, 2018-2027 (USD Billion) TABLE 6. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 7. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 8. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 9. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 10. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 11. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 12. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 13. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 14. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 15. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 16. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 17. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 18. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 19. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 20. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 21. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 22. U.S. Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 23. U.S. Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 24. U.S. Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 25. Canada Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 26. Canada Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 27. Canada Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 28. UK Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 29. UK Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 30. UK Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 31. Germany Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 32. Germany Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 33. Germany Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 34. France Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 35. France Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 36. France Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 37. Spain Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 38. Spain Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 39. Spain Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 40. Italy Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 41. Italy Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 42. Italy Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 43. China Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 44. China Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 45. China Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 46. India Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 47. India Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 48. India Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 49. Japan Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 50. Japan Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 51. Japan Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 52. Australia Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 53. Australia Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 54. Latin America Meningococcal Vaccine Market estimate & forecasts, 2018-2027 (USD Billion) TABLE 55. ROW Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 56. ROW Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 57. ROW Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 58. List of secondary sources, used in the study of global Meningococcal Vaccine Market TABLE 59. List of primary sources, used in the study of global Meningococcal Vaccine Market TABLE 60. Years considered for the study TABLE 61. Exchange rates consideredList of figures FIG 1. Global Meningococcal Vaccine Market, research methodology FIG 2. Global Meningococcal Vaccine Market, market estimation techniques FIG 3. Global market size estimates & forecast methods FIG 4. Global Meningococcal Vaccine Market, key trends 2018 FIG 5. Global Meningococcal Vaccine Market, growth prospects 2018-2027 FIG 6. Global Meningococcal Vaccine Market, porters 5 force model FIG 7. Global Meningococcal Vaccine Market, pest analysis FIG 8. Global Meningococcal Vaccine Market, value chain analysis FIG 9. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 10. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 11. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 12. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 13. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 14. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 15. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 16. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion) FIG 17. Global Meningococcal Vaccine Market, regional snapshot 2018 & 2027 FIG 18. North America Meningococcal Vaccine Market 2018 & 2027 (USD Billion) FIG 19. Europe Meningococcal Vaccine Market 2018 & 2027 (USD Billion) FIG 20. Asia-Pacific Meningococcal Vaccine Market 2018 & 2027 (USD Billion) FIG 21. Latin America Meningococcal Vaccine Market 2018 & 2027 (USD Billion) FIG 22. Global Meningococcal Vaccine Market, company market share analysis (2018)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: Bizwit Research & Consulting LLP
Chat with us